Form D · Biotechnology
Gilero Group, LLC
Morrisville, NC · CIK 0001857663
Offering snapshot reported May 14, 2021 · SEC filing
- Reported sold
- $4.49M Offering amount: $11.5M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 14, 2021 | Initial | $4,489,115 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-399402
Source: Form D, filed May 14, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Margherita Boiero | Director |
| Todd Korogi | Director |
| Ted Mosler | Director |
| Charles Stroupe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
635 Davis Dr Unit 100
Morrisville, NC, 27560
Morrisville, NC, 27560